Kazuo Sugimoto
Overview
Explore the profile of Kazuo Sugimoto including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
33
Citations
237
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Jia Q, Song Y, Zhang C, Li M, Feng L, Sugimoto K, et al.
BMC Complement Med Ther
. 2024 Jun;
24(1):231.
PMID: 38867220
Background And Aim: Traditional Chinese medicine (TCM) is widely used by patients with amyotrophic lateral sclerosis (ALS). However, their reasons and experience in using TCM have received insufficient attention. Therefore,...
2.
Zou T, Sugimoto K, Zhao Y, Li B, Zhou X, Peng C
J Cell Mol Med
. 2024 May;
28(11):e18365.
PMID: 38818577
Traditional Chinese medicine, particularly Zhi-zi-chi decoction (ZZCD), is gaining recognition as a potential treatment for depression. This study aimed to uncover the molecular mechanisms behind ZZCD's antidepressant effects, focusing on...
3.
Liang H, Ma Z, Zhong W, Liu J, Sugimoto K, Chen H
Phytother Res
. 2024 Feb;
38(4):1838-1862.
PMID: 38356178
Mitochondrial damage is associated with the development of Parkinson's disease (PD), indicating that mitochondrial-targeted treatments could hold promise as disease-modifying approaches for PD. Notably, natural compounds have demonstrated the ability...
4.
Liu J, Shao X, Fan J, Wang Y, Cao Y, Tan G, et al.
Ann Clin Transl Neurol
. 2023 Dec;
11(2):436-449.
PMID: 38069466
Objective: Neuromyelitis optica spectrum disorder (NMOSD) is an autoimmune-mediated disorder with aquaporin 4-immunoglobulin G (AQP4-IgG) in most settings. Soluble programmed death-1 (sPD-1) and soluble programmed death ligand 1 (sPD-L1) play...
5.
Lin M, Hu L, Shen S, Liu J, Liu Y, Xu Y, et al.
Stroke Vasc Neurol
. 2023 Jun;
9(2):108-125.
PMID: 37311641
Background: Atherosclerosis (AS) and tumours are the leading causes of death worldwide and share common risk factors, detection methods and molecular markers. Therefore, searching for serum markers shared by AS...
6.
Liu J, Zhang C, Xie Y, Zhou L, Guo L, Li B, et al.
Front Pharmacol
. 2022 Dec;
13:981300.
PMID: 36518667
Traditional Chinese medicine (TCM), a main form of complementary and alternative medicine provides a potential possibility for demyelinating disease of the central nervous system (DDC) management and has been applied...
7.
Ito M, Hiwasa T, Yajima S, Suzuki T, Oshima Y, Nanami T, et al.
Esophagus
. 2022 Jul;
19(4):617-625.
PMID: 35780443
Background: Cofilin (CFL1, actin-binding protein) and β-actin (ACTB) are key molecules in the polymerization and depolymerization of actin microfilaments. The levels of these antibodies were analyzed, and the clinicopathological significance...
8.
Hu L, Liu J, Shimada H, Ito M, Sugimoto K, Hiwasa T, et al.
Front Oncol
. 2022 Jun;
12:870086.
PMID: 35656505
Atherosclerosis (AS) and cancers are major global causes of mortality and morbidity. They also share common modifiable pathogenesis risk factors. As the same strategies used to predict AS could also...
9.
Liu J, Tan G, Li B, Zhang J, Gao Y, Cao Y, et al.
Front Neurol
. 2021 Nov;
12:746959.
PMID: 34744983
Aquaporin 4-immunoglobulin G (AQP4-IgG) plays a major role in the pathogenesis of neuromyelitis optica spectrum disorder (NMOSD). Seropositive status for this antibody has become one of the required indicators for...
10.
Sugimoto K, Liu J, Li M, Song Y, Zhang C, Zhai Z, et al.
Front Pharmacol
. 2021 Nov;
12:701886.
PMID: 34737697
Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease, in the pathogenesis of which oxidative stress (OS) was believed to play a key role. Shenqi Fuzheng Injection (SFI) concocted from...